Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

193
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
193
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

232
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
232
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.9K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

60
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medication-Wide Association Study of Alzheimer's Disease and Related Dementias: Identifying Drug Candidates from Electronic Health Records through Explainable AI.

medRxiv : the preprint server for health sciences·2026
Same author

Genetic Diversification in a New Guinean Frog Genus (<i>Mantophryne</i>, Microhylidae) was Driven by Ancient Tectonic Activity and Climate Reorganisation.

Ecology and evolution·2026
Same author

Characteristics and Outcomes of Over 1 Million Veterans With Heart Failure Phenotyped Using Artificial Intelligence Approaches: the National DCVA-HF Registry.

Journal of cardiac failure·2026
Same author

Beware the Little Foxes that Spoil the Vines: Small Inconsistencies in Clinical Data Can Distort Machine Learning Findings.

Fortune journal of health sciences·2026
Same author

Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF.

European journal of heart failure·2026
Same author

Serum Magnesium and Outcomes in U.S. Veterans with Heart Failure.

The American journal of medicine·2026

Related Experiment Video

Updated: Mar 2, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.3K

Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study.

Carrie M Christensen1, Rebecca S Morris2, Seraphine Chepkemoi Kapsandoy2

  • 1Department of Biomedical Informatics, University of Utah School of Medicine, 421 Wakara Way, Suite 140, Salt Lake City, UT, 84108, USA. c.m.christensen@utah.edu.

BMC Complementary and Alternative Medicine
|May 21, 2017
PubMed
Summary

Patients often use complementary and alternative medicine (CAM) but don't always tell their doctors. They want alerts about potential herb-drug-disease interactions, delivered through multiple channels.

Keywords:
AlertsComplementary and alternative medicineStructured interview study

More Related Videos

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

Related Experiment Videos

Last Updated: Mar 2, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.3K
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

Area of Science:

  • Integrative Medicine
  • Patient Safety
  • Health Communication

Background:

  • Complementary and alternative medicine (CAM) is widely used, yet patient-provider communication regarding its use is inconsistent.
  • Hazardous interactions between CAM therapies and prescription drugs are a significant concern.
  • Patients often do not inform healthcare providers about their CAM usage.

Purpose of the Study:

  • To explore patient information needs and preferences for herb-drug-disease interaction alerts.
  • To understand how to best deliver timely and integrative communication support regarding CAM use.

Main Methods:

  • A structured interview study was conducted with 50 participants at the University of Utah Hospital.
  • Qualitative methods were employed to analyze patient preferences for interaction alerts.
  • Participants provided input on desired formats and delivery methods for alerts.

Main Results:

  • A majority of participants reported current or past use of CAM therapies.
  • Most respondents expressed interest in receiving alerts about potential herb-drug-disease interactions.
  • Patients preferred receiving alerts through various channels, including in-person and electronic methods.

Conclusions:

  • There is a clear demand for healthcare interventions that support integrative communication about CAM.
  • Delivering herb-drug-disease interaction alerts through multiple channels can address critical patient information needs.
  • Improving communication about CAM use is essential for enhancing patient safety and integrated care.